COMBINED USE OF (+)-1,4-DIHYDRO-7-((3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL)-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID AND CYTARABINE (ARA-C) FOR THE TREATMENT OF LEUKEMIA
ADELMAN DANIEL C.,ADELMAN Daniel C.,SILVERMAN JEFFREY A.,SILVERMAN Jeffrey A.,MICHELSON GLENN,MICHELSON Glenn,SCATENA CAROLINE DARNE,SCATENA Caroline Darne
申请号：
SI200731723
公开号：
SI2049109T1
申请日:
2007.08.02
申请国别(地区):
SI
年份:
2016
代理人:
摘要：
Methods of treating, preventing or managing hematologic disorders, such as leukemia are disclosed. The methods encompass the administration of SNS-595. Also provided are methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. In certain embodiments, the method of treatment comprise administering SNS-595 in combination with Ara-C.
